China dominates ongoing-planned trials researching cervical cancer
Global cervical cancer immunisation with HPV vaccines has been low, with a recent study putting immunisation coverage at 12.2%.
By
Global cervical cancer immunisation with HPV vaccines has been low, with a recent study putting immunisation coverage at 12.2%.
By GlobalData HealthcareT1D is more severe than type 2 diabetes and can damage major organs.
By GlobalData HealthcareAn abstract on the MOMENTUM trial was provided at this year’s ASCO conference, published on 2 June.
By GlobalData HealthcareMerck’s latest bet is to generate clinical evidence using digitally simulated ‘predicted outcomes’ rather than actual patients.
By GlobalData HealthcareThe number of decentralised/virtual clinical trials and trials involving mobile healthcare more than doubled from 2019 to 2021.
By GlobalData HealthcareIf approved, zavegepant will be the first and only intranasal treatment for migraine in the gepant drug class.
By GlobalData HealthcareGlobalData expects Bristol-Myers Squibb’s Camzyos (mavacamten) to generate nearly $1bn in sales worldwide by the year 2025.
By GlobalData HealthcareThe bronchiectasis space boasts a modest pipeline of 14 agents for all phases, which is indicative of an overall…
By GlobalData HealthcareCovid-19 vaccines and therapeutics have been developed at a much more rapid speed than those developed for other viral…
By GlobalData HealthcareThank you for subscribing to Clinical Trials Arena